Elafin drives poor outcome in high grade serous ovarian cancers and basal-like breast tumors

High grade serous ovarian carcinoma (HGSOC) and basal-like breast cancer (BLBC) share many features including TP53 mutations, genomic instability and poor prognosis. We recently reported that Elafin is overexpressed by HGSOC and is associated with poor overall survival. Here, we confirmed that Elafi...

詳細記述

保存先:
書誌詳細
主要な著者: Labidi-Galy, S. Intidhar, Clauss, Adam, Ng, Vivian, Duraisamy, Sekhar, Elias, Kevin M., Piao, Hui-Ying, Bilal, Erhan, Davidowitz, Rachel A., Lu, Yiling, Badalian-Very, Gayane, Györffy, Balázs, Kang, Un-Beom, Ficarro, Scott B., Ganesan, Shridar, Mills, Gordon B., Marto, Jarrod A., Drapkin, Ronny
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112176/
https://ncbi.nlm.nih.gov/pubmed/24469047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2013.562
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料